Latest filing published 29 Sept 2022 for Tissue Regenix Group plc, €11k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Daniel Lee: trading record in brief
Daniel Lee discloses dealings in Tissue Regenix Group plc to RNS (LSE). We count 3 filings; the first trade dates from 10 May 2021 and the latest from 28 September 2022.
Purchases make up the whole of the open-market record (3 purchases, €37k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2022: 2 purchases and no sales on the market.
In size, the median ticket on the buying side is €11k. Of 3 purchases, 2 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
On 29 September 2022 came the latest disclosure, an open-market purchase for €11k in Tissue Regenix Group plc. Between a trade and the moment it shows up on RNS (LSE), the median delay is 1 day. The regulation allows three business days to notify a trade (UK MAR). Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to Daniel Lee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000,000 shares@ £0.004829.4% of flowLondon Stock Exchange, AIM MarketISIN GB00B5SGVL29FCA-NSM:4527051Canonical exit: 27 Dec 2022 (T+90)
- 1,785,000 shares@ £0.004425.6% of flowLondon Stock Exchange, AIM MarketISIN GB00B5SGVL29FCA-NSM:4330505-0Canonical exit: 4 Jul 2022 (T+90)
- 2,068,750 shares@ £0.006945.1% of flowLondon Stock Exchange, AIM MarketISIN GB00B5SGVL29FCA-NSM:3969816Canonical exit: 8 Aug 2021 (T+90)
3 of 3 declarations